Nucleus Genomics
Curated by SignalProvider of genetic testing kits for rare variant analysis
Overview
Provider of genetic testing kits for rare variant analysis. The company offers direct to consumer genetic testing platform that provides genetic risk and disposition score analyses on an extensive number of diseases and traits by leveraging whole-genome sequencing (WGS).
Key facts
- Founded
- 2021
- Headquarters
- Manhattan, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Primary office
- Sign up to view